AbolerIS Pharma
Antoine THOMAS is a seasoned professional in the field of CMC (Chemistry, Manufacturing, and Controls) with extensive experience in biopharmaceuticals and gene therapy. Currently serving as the Head of CMC at AbolerIS Pharma, Antoine also operates as the Owner and Senior CMC Consultant at ATBio-Consulting and holds the position of Head of External Manufacturing at ExeVir. Antoine has previously held roles such as VP of External Manufacturing at TargED Biopharmaceuticals and Sr. CMC Manager at Vivet Therapeutics, where responsibilities included technical project management and strategy development for gene therapy projects. Early career experiences include leadership roles at Ablynx and UCB Pharma, focusing on process development and project leadership. Antoine holds a PhD and a Master's degree in Organic Chemistry from Université Henri Poincaré, along with ongoing GMP professional training from the European Compliance Academy.
AbolerIS Pharma
AbolerIS Pharma will develop novel and unique therapeutic approaches to induce immune tolerance and preserves useful immune responses in inflammatory, autoimmune and degenerative diseases. Anti-CD45RC monoclonal antibody to deplete effector T cells and preserve regulatory and memory T cells. IL-34 cytokine to induce tolerogenic macrophages/DCs and regulatory T cells. Founded by a team with a long cutting-edge translational expertise in regulatory T cells and mechanisms of tolerance.